From the Zeiss blurb in their email promoting EANS 2018
"CONVIVO® from ZEISS1 brings a powerful digital visualization technology into the operating room.
For the first time neurosurgeons and pathologists are able to perform a digital biopsy without the need for tissue extraction. This may help to support the resection of brain tumors in the future.
Curious to see how tissue microstructure can be visualized in real-time? Then meet us at the booth for more information.
As we get closer to the event, we will keep you updated with the complete event schedule that we are putting together for you".
That's a pretty clear demonstration of Zeiss's intent and one I would agree should be shared with shareholders of Optiscan. Let's hope it's part of Optiscan's spiel, due out any day now, I hope
From the Zeiss blurb in their email promoting EANS 2018...
Add OIL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $129.4M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 16.5¢ | 16.0¢ | $23.08K | 143.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49548 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 73836 | 2 |
View Market Depth
| Last trade - 16.10pm 29/11/2024 (20 minute delay) ? |
| OIL (ASX) Chart |
